Skip to main content
Caplight Logo









EpiWatch, Inc.

EpiWatch, Inc.

Private
Baltimore, MarylandHealthcare & Life Scienceshttps://epiwatch.com/

Last Round

VC Round

Jul 22, 2025

Total Funding Raised

$1.18M

Company Overview

EpiWatch, Inc. is a healthcare technology company that provides a digital care platform designed to manage epilepsy by detecting and alerting for seizures.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Patient Engagement

Business Model

B2C

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

seizure detectiondigital healthsoftware as a medical deviceSaMDepilepsy monitoringdigital therapeuticsDTxwearable health techseizure alert systemFDA-cleared appremote patient monitoringRPMsmartwatch health apptonic-clonic seizureprescription digital therapymHealth

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EpiWatch, Inc. Comparables

Compare EpiWatch, Inc. with similar companies based on industry and business-model similarity.

EpiWatch, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Epipal
86%
Smart Monitor
85%
My Medic Watch
84%

EpiWatch, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJul 22, 2025
AcceleratorJun 5, 2025
GrantJun 1, 2024
Seed RoundJan 22, 2024
Early FundingJun 6, 2023
Early Funding
Aug 1, 2022

Key People

Founding team and executive leadership

Teresa Prego

Chief Executive Officer

Executive Team

EpiWatch, Inc. Investors

Notable investors and investment history

EpiWatch, Inc. investors
InvestorRounds
Iaso VenturesEarly Funding, Seed
MedTech InnovatorAccelerator
NIH RADxGrant
TEDCOEarly Funding, Seed
Johns Hopkins Technology VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 5, 2025

    Received funding from MedTech Innovator.

  • Aug 1, 2022

    Raised capital from Iaso Ventures and epilepsy-ventures-fund.

EpiWatch, Inc. Filings

Explore SEC and related filing metadata, where available.

EpiWatch, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about EpiWatch, Inc.'s valuation, stock price, and market status.

Is EpiWatch, Inc. a public or private company?

EpiWatch, Inc. is a private company.

What is the current stock price of EpiWatch, Inc.?

EpiWatch, Inc. is a private company, so its shares have no public market price. Caplight tracks EpiWatch, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is EpiWatch, Inc. worth (valuation)?

Valuation information for EpiWatch, Inc. is not publicly available.

Can I buy EpiWatch, Inc. stock?

EpiWatch, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was EpiWatch, Inc.'s last funding round?

EpiWatch, Inc.'s most recent funding round was VC Round on July 22, 2025.

Who are the main investors in EpiWatch, Inc.?

Key investors in EpiWatch, Inc. include TEDCO.

Will EpiWatch, Inc. IPO soon?

No public IPO plans have been announced for EpiWatch, Inc..

How can I track EpiWatch, Inc. secondary market activity?

Caplight tracks bids, offers, and trades in EpiWatch, Inc.'s shares on secondary markets.

Firmographic Details

HeadquartersBaltimore, Maryland
Employee Range8
Year Founded2020
Last FundingJul 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?